Back to top
more

Tilray Brands (TLRY)

(Delayed Data from NSDQ)

$2.07 USD

2.07
18,809,488

-0.02 (-0.96%)

Updated May 15, 2024 04:00 PM ET

After-Market: $2.06 -0.01 (-0.48%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value D Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 28% (71 out of 250)

Industry: Consumer Products - Staples

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Tilray, Inc. (TLRY) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, Tilray, Inc. (TLRY) closed at $27.47, marking a +1.85% move from the previous day.

Sweta Killa headshot

Cannabis ETF (MSOS) On a High, Reaches $1B AUM Milestone

by Sweta Killa

AdvisorShares Pure US Cannabis ETF (MSOS) has been surging in popularity with its assets growing more than 40,000% in just six months.

Do Options Traders Know Something About Tilray (TLRY) Stock We Don't?

by Zacks Equity Research

Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.

Mark Vickery headshot

Markets Break Higher; NVIDIA Beats Q4 Expectations

by Mark Vickery

NVIDIA (NVDA) beat estimates on both top and bottom lines after regular trading this afternoon.

Neena Mishra headshot

Should You Invest in Marijuana Stocks & ETFs Now?

by Neena Mishra

CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.

Mark Vickery headshot

Dow Sets New High; Tilray & Twilio Beat

by Mark Vickery

Cannabis supply giant Tilray (TLRY) is up 14% in the late market, following a 9% sell-off in regular day trading.

Tilray, Inc. (TLRY) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Tilray, Inc. (TLRY) delivered earnings and revenue surprises of 42.86% and 1.82%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Tilray (TLRY) to Report Q4 Earnings: What's in the Cards?

by Zacks Equity Research

Investors will focus on revenue growth and other pipeline updates, when Tilray (TLRY) reports fourth-quarter 2020 results.

Sanghamitra Saha headshot

Marijuana ETFs on a High on Reddit Frenzy

by Sanghamitra Saha

After promoting GameStop (GME) and Silver, Reddit's discussion has now popularized marijuana stocks like Sundial Growers (up 78.8% on Feb 10) and Tilray (up more than 50% on Feb 10).

Meridian Bioscience, CRISPR Therapeutics, Tilray and Uber highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Meridian Bioscience, CRISPR Therapeutics, Tilray and Uber highlighted as Zacks Bull and Bear of the Day

3 Stocks to Benefit From the Rapid Adoption of Marijuana

by Zacks Equity Research

The marijuana industry looks set to witness growth going forward due to wider adoption, making it prudent to look at names like Scotts Miracle-Gro (SMG), GrowGeneration (GRWG) and Tilray (TLRY)

Mark Vickery headshot

Tilray Bought by the Reddit Crowd, Plus UBER's Q3

by Mark Vickery

Shares of the marijuana pharma company shot up another 51% Wednesday, following a +44% performance yesterday; Tilray is now up 400% in just the last month alone.

Cannabis Stocks Rise on Hopes of Federal Legalization in US

by Zacks Equity Research

Cannabis stocks seem poised to gain on hopes of removal of the federal ban on cannabis products under the new administration.

The Zacks Analyst Blog Highlights: Canopy Growth, Tilray, Cisco Systems, Twitter and Lyft

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Canopy Growth, Tilray, Cisco Systems, Twitter and Lyft

Mark Vickery headshot

Pot Stocks Take Markets Higher; Plus Beats for Cisco, Twitter, Lyft

by Mark Vickery

With Tilray (TLRY) +44% and Canopy (CGC) +12% on the day, the Nasdaq and Russell 2000 managed to climb to fresh all-time highs Tuesday.

Sweta Killa headshot

Cannabis ETFs Spike on Jazz-GW Pharma Deal

by Sweta Killa

Jazz Pharmaceuticals (JAZZ) agreed to buy cannabinoid drug company GW Pharmaceuticals (GWPH) for $7.2 billion in cash and stock that has strengthened the bullish case for the cannabis industry.

Sweta Killa headshot

Cannabis ETF Tops in January: 5 Stocks That Led the Way

by Sweta Killa

Inside the top performing stocks in the top ETF of January.

Sunoco, Lemonade, Tilray, Innovative Industrial Properties and Square highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Sunoco, Lemonade, Tilray, Innovative Industrial Properties and Square highlighted as Zacks Bull and Bear of the Day

Tirthankar Chakraborty headshot

3 Marijuana Stocks to Play the Green Rush in 2021

by Tirthankar Chakraborty

Marijuana stocks are set to be the rage on Wall Street in hopes of legalization in and around the United States, which calls for keeping an eye on the likes of Tilray (TLRY) and Square (SQ).

Is Tilray (TLRY) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Is (TLRY) Outperforming Other Medical Stocks This Year?

The Zacks Analyst Blog Highlights: NVIDIA, JPMorgan, Beazer Homes USA, Tesla and Tilray

by Zacks Equity Research

The Zacks Analyst Blog Highlights: NVIDIA, JPMorgan, Beazer Homes USA, Tesla and Tilray

Tirthankar Chakraborty headshot

Here're the 5 Top Stock Trades for 2021

by Tirthankar Chakraborty

We have highlighted stocks worth a look from the five best trading areas of the current year. This includes NVIDIA (NVDA), JPMorgan Chase (JPM), Beazer Homes (BZH), Tesla (TSLA) and Tilray (TLRY).

Tilray (KL) Looks Good: Stock Adds 5.3% in Session

by Zacks Equity Research

Tilray (KL) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

Is the Options Market Predicting a Spike in Tilray (TLRY) Stock?

by Zacks Equity Research

Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.

Sweta Killa headshot

ETFs to Buy as Tilray-Aphria Merger Creates Cannabis Giant

by Sweta Killa

Investors seeking to take advantage of the merger deal between Tilray and Aphria could invest in any of the cannabis ETFs.